A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/715 (2006.01) A61K 31/726 (2006.01) A61K 31/727 (2006.01) A61P 25/28 (2006.01) C08B 37/00 (2006.01)
Patent
CA 2373975
The present invention relates to the use of glycosaminoglycans having an average molecular weight equal to 2,400 D for the preparation of pharmaceutical compositions suitable for the treatmet of senile dementia, in particular for the treatment of Alzheimer's disease or SDAT (Senile Dementia Alzheimer's Type) and of the cerebral neurological lesions from ictus and from traumas.
L'invention concerne l'utilisation de glycosaminoglycanes de poids moléculaire moyen égal à 2.400 D pour préparer des compositions pharmaceutiques appropriées pour traiter la démence sénile, en particulier pour traiter la maladie d'Alzheimer ou la démence sénile de type Alzheimer et les lésions neurologiques cérébrales résultant d'ictus et de traumatismes.
Cornelli Umberto
de Ambrosi Luigi
Fareed Jawed
Hanin Israel
Lee John
Cornelli Umberto
Marks & Clerk
LandOfFree
Glycosaminoglycans having an average molecular weight equal... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glycosaminoglycans having an average molecular weight equal..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glycosaminoglycans having an average molecular weight equal... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1526480